Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Vera Therapeutics Inc (NASDAQ: VERA) closed the day trading at $22.19 down -2.25% from the previous closing price of $22.70. In other words, the price has decreased by -$2.25 from its previous closing price. On the day, 2.03 million shares were traded. VERA stock price reached its highest trading level at $23.2176 during the session, while it also had its lowest trading level at $21.3783.
Ratios:
For a better understanding of VERA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 27.30 and its Current Ratio is at 27.30. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.
On February 04, 2025, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $49.
On January 28, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $58.Goldman initiated its Buy rating on January 28, 2025, with a $58 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 21 ’25 when Fordyce Marshall sold 10,613 shares for $27.89 per share. The transaction valued at 296,032 led to the insider holds 213,740 shares of the business.
Fordyce Marshall sold 9,075 shares of VERA for $250,882 on Feb 26 ’25. The PRESIDENT AND CEO now owns 204,665 shares after completing the transaction at $27.65 per share. On Feb 26 ’25, another insider, MARSHALL FORDYCE, who serves as the Director of the company, bought 9,075 shares for $27.10 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 1447673472 and an Enterprise Value of 879779584.
Stock Price History:
The Beta on a monthly basis for VERA is 1.14, which has changed by -0.4225865 over the last 52 weeks, in comparison to a change of 0.11730647 over the same period for the S&P500. Over the past 52 weeks, VERA has reached a high of $51.61, while it has fallen to a 52-week low of $18.53. The 50-Day Moving Average of the stock is -2.07%, while the 200-Day Moving Average is calculated to be -36.27%.
Shares Statistics:
Over the past 3-months, VERA traded about 1.56M shares per day on average, while over the past 10 days, VERA traded about 4547220 shares per day. A total of 63.77M shares are outstanding, with a floating share count of 48.07M. Insiders hold about 24.63% of the company’s shares, while institutions hold 90.09% stake in the company. Shares short for VERA as of 1747267200 were 7069204 with a Short Ratio of 4.55, compared to 1744675200 on 6078809. Therefore, it implies a Short% of Shares Outstanding of 7069204 and a Short% of Float of 12.770000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The firm’s stock currently is rated by 7.0 analysts. The consensus estimate for the next quarter is -$0.83, with high estimates of -$0.66 and low estimates of -$0.94.
Analysts are recommending an EPS of between -$2.79 and -$3.86 for the fiscal current year, implying an average EPS of -$3.35. EPS for the following year is -$2.98, with 5.0 analysts recommending between -$2.28 and -$3.74.
Revenue Estimates
Based on 12 analysts’ estimates, the company’s revenue will be $37.08M in the next fiscal year. The high estimate is $81.7M and the low estimate is $2.57M.
